★ WIDE MOAT STOCKS & COMPETITIVE ADVANTAGES ★
VOL. XCIV, NO. 247
Stock Profile
Koninklijke Philips N.V. (PHIA) Moat Analysis
Koninklijke Philips N.V.
PHIA · Euronext Amsterdam
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Request update
Spot something outdated? Send a quick note and source so we can refresh this profile.
Overview
Royal Philips reports Diagnosis & Treatment, Connected Care and Personal Health. Its best-supported advantages are hospital workflow embedding through imaging and monitoring informatics, service coverage around a large installed base, and consumer brand trust with attached consumables. These advantages face open standards, vendor-neutral archives, hospital procurement power and easy consumer switching. H1 2026 comparable sales grew 4%; Diagnosis & Treatment grew 2%, Connected Care 3% and Personal Health 9%. The reported margin improvement includes a EUR 186 million US tariff refund, while Diagnosis & Treatment adjusted EBITA declined excluding that benefit. Respironics remains the largest trust risk: consent-decree and field-action costs continued, and US and Australian investigations remain open. Current guidance excludes those proceedings.
Primary segment
Diagnosis & Treatment
Market structure
Oligopoly
Market share
—
HHI: —
Coverage
3 segments · 6 tags
Updated 2026-08-23
Segments
Diagnosis & Treatment
Medical imaging, image-guided therapy systems, and enterprise imaging informatics
Revenue
49.7%
Structure
Oligopoly
Pricing
moderate
Share
—
Peers
Connected Care
Patient monitoring, clinical workflow software (enterprise informatics), and sleep & respiratory care
Revenue
28.4%
Structure
Oligopoly
Pricing
moderate
Share
—
Peers
Personal Health
Premium personal health devices (oral care, grooming, mother & childcare, beauty devices)
Revenue
21.9%
Structure
Competitive
Pricing
weak
Share
—
Peers
Moat Claims
Diagnosis & Treatment
Medical imaging, image-guided therapy systems, and enterprise imaging informatics
H1 2026 revenue share uses Diagnosis & Treatment sales of EUR 3,933m versus EUR 7,906m across the three operating segments, excluding Other. Operating-profit share uses adjusted EBITA of EUR 470m versus EUR 1,051m across those segments.
Data Workflow Lockin
Demand
Data Workflow Lockin
Strength
Durability
Confidence
Evidence
Enterprise imaging informatics (PACS + interoperability) integrated with imaging systems anchors hospital imaging workflows and raises switching costs.
Data Workflow Lockin moat: definition, examples, and stocks
Erosion risks
- Cloud-native PACS/VNA reducing vendor lock-in
- Open standards (DICOM/HL7/FHIR) improving interoperability
- Hospitals pushing best-of-breed point solutions
Leading indicators
- PACS/informatics renewal win rate
- Interoperability platform attach rate on imaging deals
- Software and services recurring revenue mix
Counterarguments
- Vendor-neutral archives and cloud PACS can reduce switching friction
- Radiology departments can operate multi-vendor imaging fleets
Service Field Network
Supply
Service Field Network
Strength
Durability
Confidence
Evidence
Large installed base supports service contract attachment, uptime guarantees, and upgrade pathways that raise customer switching friction.
Service Field Network moat: definition, examples, and stocks
Erosion risks
- Growth of third-party servicing (ISOs)
- Service/right-to-repair regulation increasing parts access
- Hospital budget pressure forcing service repricing
Leading indicators
- Service contract attachment rate
- Service gross margin trend
- Customer uptime/SLA performance metrics
Counterarguments
- Large health systems can insource maintenance
- ISOs can service mature modalities at lower cost
Connected Care
Patient monitoring, clinical workflow software (enterprise informatics), and sleep & respiratory care
H1 2026 revenue share uses Connected Care sales of EUR 2,245m versus EUR 7,906m across the three operating segments, excluding Other. Operating-profit share uses adjusted EBITA of EUR 242m versus EUR 1,051m. Respironics incurred EUR 84m of H1 charges; US federal and state investigations and the Australian regulator review remain ongoing.
Data Workflow Lockin
Demand
Data Workflow Lockin
Strength
Durability
Confidence
Evidence
Monitoring + enterprise informatics software embed into clinical workflows (alarms, dashboards, documentation), making rip-and-replace costly and risky for hospitals.
Data Workflow Lockin moat: definition, examples, and stocks
Erosion risks
- EHR/platform consolidation changing integration dynamics
- Cybersecurity incidents undermining trust
- Regulatory constraints on data sharing/AI
Leading indicators
- Enterprise informatics renewal rates
- Installed monitor fleet expansion in existing customers
- Net retention of software/services in health systems
Counterarguments
- EHR vendors can subsume monitoring workflows and analytics
- Hospitals can standardize on competitor ecosystems at refresh cycles
Personal Health
Premium personal health devices (oral care, grooming, mother & childcare, beauty devices)
H1 2026 revenue share uses Personal Health sales of EUR 1,728m versus EUR 7,906m across the three operating segments, excluding Other. Operating-profit share uses adjusted EBITA of EUR 339m versus EUR 1,051m.
Brand Trust
Demand
Brand Trust
Strength
Durability
Confidence
Evidence
Trusted consumer brand supports premium shelf/online placement and repeat purchasing in oral care and grooming categories.
Brand Trust moat: definition, examples, and stocks
Erosion risks
- Price competition and private label pressure
- Retailer shelf-space/online ranking shifts
- Negative reviews from quality issues
Leading indicators
- Premium mix and ASP trend
- Product review ratings and return rates
- Share of branded search / D2C repeat purchase rates
Counterarguments
- Switching costs are low; consumers chase promotions
- Competitors can replicate features quickly
Installed Base Consumables
Demand
Installed Base Consumables
Strength
Durability
Confidence
Evidence
Installed base of devices can drive recurring attachment sales (e.g., blades, heads), improving repeat economics versus one-time device sales.
Installed Base Consumables moat: definition, examples, and stocks
Erosion risks
- Third-party compatible replacement parts
- Retail substitution toward cheaper accessories
- Consumer backlash against proprietary consumables
Leading indicators
- Consumables revenue growth vs device revenue
- Repeat purchase rates in D2C channels
- Mix shift toward proprietary vs compatible attachments
Counterarguments
- Generics can commoditize attachments and compress margins
- Consumers can switch platforms at the next device purchase
Evidence
Enabled by industry leading Enterprise Informatics #1 in PACS and inter-operability
Supports workflow/data lock-in via leading PACS and interoperability positioning in imaging informatics.
signed long-term enterprise imaging partnerships
Current US and UK cloud-imaging partnerships connect care teams and patient information across clinical workflows.
Market leading installed base
Installed base scale underpins service footprint and recurring services.
~40% of sales from recurring revenues
Recurring revenue mix is consistent with meaningful service/software/consumables contribution.
modernize more than 200 hospitals
More than 300 imaging, image-guided therapy and monitoring projects demonstrate current deployment and service breadth.
Showing 5 of 11 sources.
Risks & Indicators
Erosion risks
- Cloud-native PACS/VNA reducing vendor lock-in
- Open standards (DICOM/HL7/FHIR) improving interoperability
- Hospitals pushing best-of-breed point solutions
- Growth of third-party servicing (ISOs)
- Service/right-to-repair regulation increasing parts access
- Hospital budget pressure forcing service repricing
Leading indicators
- PACS/informatics renewal win rate
- Interoperability platform attach rate on imaging deals
- Software and services recurring revenue mix
- Service contract attachment rate
- Service gross margin trend
- Customer uptime/SLA performance metrics
Research PHIA elsewhere
Keep the research going
More Rankings & Systems
Quality Stocks
High quality stocks ranked by profitability, margins, free cash flow quality, durability, solvency, and accounting...
Stock rankingUndervalued Stocks
Undervalued stocks from the NA & Europe universe, ranked with a multi-measure value system and quality controls.
Stock rankingDividend Stocks
Dividend stocks ranked by payout yield, payout sustainability, dividend growth, quality, balance-sheet safety, risk...
Stock rankingDefensive Stocks
Defensive stocks ranked by low volatility, low beta, intermediate momentum, durable profitability, balance sheet...
Stock rankingMomentum Stocks
Momentum stocks ranked by total return momentum, relative momentum, trend confirmation, and risk-adjusted momentum...
Stock rankingConviction 10
A concentrated 10-stock strategy from the NA & Europe universe, ranked across quality, value, growth, momentum, and...
Curation & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.